| 臺大學術典藏 |
2021-08-24T08:23:34Z |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee Y.-L.; Lin K.-Y.; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Tang H.-J.; Lin T.-Y.; Wang N.-C.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG; Sun H.-Y.; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; Hung C.-C.; Taiwan HIV Study Group |
| 國立成功大學 |
2017 |
Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan
|
Lee, Y.-L.;Lin, K.-Y.;Cheng, Cheng C.-Y.;Li, C.-W.;Yang, C.-J.;Tsai, M.-S.;Tang, H.-J.;Lin, T.-Y.;Wang, N.-C.;Lee, Y.-C.;Lin, S.-P.;Huang, Y.-S.;Sun, H.-Y.;Zhang, J.-Y.;Ko, W.-C.;Cheng, S.-H.;Lee, Y.-T.;Liu, C.-E.;Hung, C.-C.;Group, Taiwan HIV Study |
| 國立臺灣大學 |
2007 |
Evolution of Hepatitis B Serological Markers in Hiv-Infected Patients Receiving Highly Active Antiretroviral Therapy
|
盛望徽; 高嘉宏; 陳培哲; 黃立民; 張淑媛; 孫幸筠; 洪健清; 陳茂源; 張上淳; SHENG, WANG-HUEI; KAO, JIA-HORNG; CHEN, PEI-JER; HUANG, LI-MIN; CHANG, SUI-YUAN; SUN, HSIN-YUN; HUNG, CHIEN-CHING; CHEN, MAO-YUAN; CHANG, SHAN-CHWEN |
| 臺大學術典藏 |
2018-09-10T06:29:35Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng, WH;Kao, JH;Chen, PJ;Huang, LM;Chang, SY;Sun, HY;Hung, CC;Chen, MY;Chang, SC.; Sheng, W.-H. and Kao, J.-H. and Chen, P.-J. and Huang, L.-M. and Chang, S.-Y. and Sun, H.-Y. and Hung, C.-C. and Chen, M.-Y. and Chang, S.-C.; Sheng, WH; SUI-YUAN CHANG; PEI-JER CHEN; Kao, JH; WANG-HUEI SHENG; Chen, PJ; SHAN-CHWEN CHANG; Huang, LM; HSIN-YUN SUN; Chang, SY; JIA-HORNG KAO; Sun, HY; Hung, CC; CHIEN-CHING HUNG; Chen, MY; Chang, SC. |
| 臺大學術典藏 |
2020-06-18T08:26:19Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng W.-H.;Kao J.-H.;Chen P.-J.;Huang L.-M.;Sui-Yuan Chang;Sun H.-Y.;Hung C.-C.;Chen M.-Y.;Chang S.-C.; Sheng W.-H.; Kao J.-H.; Chen P.-J.; Huang L.-M.; SUI-YUAN CHANG; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2007 |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Chen M.-Y.; Chang S.-C.; Chen P.-J.; Kao J.-H.; Sheng W.-H.; Sheng W.-H.;Kao J.-H.;Chen P.-J.;Huang L.-M.;Chang S.-Y.;Sun H.-Y.;Chien-Ching Hung;Chen M.-Y.;Chang S.-C.; CHIEN-CHING HUNG; Chang S.-Y.; Sun H.-Y.; Huang L.-M. |
| 臺大學術典藏 |
2007 |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng W.-H.;Kao J.-H.;Chen P.-J.;Huang L.-M.;Chang S.-Y.;Hsin-Yun Sun;Hung C.-C.;Chen M.-Y.;Chang S.-C.; Sheng W.-H.; Kao J.-H.; Chen P.-J.; Huang L.-M.; Chang S.-Y.; HSIN-YUN SUN; Hung C.-C.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2007 |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Huang L.-M.; Kao J.-H.; Chen P.-J.; Sheng W.-H.; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; SHAN-CHWEN CHANG |
| 臺大學術典藏 |
2021-02-26T02:00:18Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Wang-Huei Sheng;Kao J.-H.;Chen P.-J.;Huang L.-M.;Chang S.-Y.;Sun H.-Y.;Hung C.-C.;Chen M.-Y.;Chang S.-C.; WANG-HUEI SHENG; Kao J.-H.; Chen P.-J.; Huang L.-M.; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-06-24T07:17:14Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng W.-H.; Kao J.-H.; Chen P.-J.; LI-MIN HUANG; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-07-03T03:35:10Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng W.-H.; Kao J.-H.; PEI-JER CHEN; Huang L.-M.; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-09-04T06:18:53Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng W.-H.; JIA-HORNG KAO; Chen P.-J.; Huang L.-M.; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C. |
| 臺大學術典藏 |
2021-12-01T02:30:10Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy
|
Sheng W.-H.; Kao J.-H.; Chen P.-J.; Huang L.-M.; Chang S.-Y.; Sun H.-Y.; CHIEN-CHING HUNG; Chen M.-Y.; Chang S.-C. |
| 國立臺灣大學 |
2007-11 |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
|
Sheng, WH; Kao, JH; Chen, PJ; Huang, LM; Chang, SY; Sun, HY; Hung, CC; Chen, MY; Chang, SC. |
| 臺大學術典藏 |
2018-09-10T06:41:18Z |
Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
|
Wang-Huei Sheng; Jia-Horng Kao; Pei-Jer Chen; Li-Ming Huang; Sui-Yuan Chang; Hsin-Yun Sun; Chien-Ching Hung; Mao-Yuan Chen; Shan-Chwen Chang; LI-MIN HUANG |
| 國立臺灣大學 |
2006-01 |
Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C
|
Chen, BF; Liu, CJ; Jow, GM; Chen, PJ; Kao, JH; Chen, DS |
| 臺大學術典藏 |
2018-09-10T06:00:27Z |
Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C
|
Chen, B.-F.; Liu, C.-J.; Jow, G.-M.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:18:59Z |
Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C
|
Chen B.-F.; Liu C.-J.; Jow G.-M.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:17Z |
Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C
|
Chen B.-F.; CHUN-JEN LIU; Jow G.-M.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:35:17Z |
Evolution of hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C
|
Chen B.-F.; Liu C.-J.; Jow G.-M.; PEI-JER CHEN; Kao J.-H.; Chen D.-S. |
| 國立臺灣大學 |
2004 |
Evolution of Hepatitis B Virus Precore/Basal Core Promoter Gene in Hbeag- Positive Chronic Hepatitis B Patients Receiving Lamivudine Therapy
|
林志陵; 廖麗瑛; 王朝欣; 陳培哲; 賴明陽; 陳定信; 高嘉宏; LIN, CHIH-LIN; LIAO, LI-YING; WANG, CHAUR-SHINE; CHEN, PEI-JER; LAI, MING-YANG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T04:57:28Z |
Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy
|
Lin, C.-L.;Liao, L.-Y.;Wang, C.-S.;Chen, P.-J.;Lai, M.-Y.;Chen, D.-S.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-07-03T03:35:36Z |
Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy
|
Lin C.-L.; Liao L.-Y.; Wang C.-S.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:19:09Z |
Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy
|
Lin C.-L.; Liao L.-Y.; Wang C.-S.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO |
| 國立臺灣大學 |
1997-07 |
Evolution of hepatitis C virus quasi- species in mothers and infants infected through mother to infant transmission.
|
Ni, YH; Chang, MH; Chen, PJ; Lin, HH; Hsu, HY |
